A DUAL-ASSET STRATEGY

COMBATTING URGENT VIRAL DISEASE THREATS

Island Pharmaceuticals is developing clinical-stage antiviral therapies targeting high-impact infectious diseases through a differentiated drug repurposing strategy.

Learn more
Learn more

ASX : ILA

Last Update: 02 Apr 2026

ASX Announcements

Advancing Antiviral Therapeutics for Global Health

TWO PROGRAMS TARGETING INFECTIOUS DISEASES

Island Pharmaceuticals is advancing a targeted portfolio of antiviral programs with significant market potential. Supported by prior clinical data and clear regulatory pathways, the company is advancing toward key near-term milestones.

Learn more
Learn more
Logo Only

Galidesivir

Galidesivir is a broad-spectrum antiviral with activity against more than 20 RNA viruses, including Ebola and Marburg.

Logo Only

Isla-101

A clinical-stage antiviral therapy addressing dengue and other mosquito-borne diseases, supported by prior human safety data.

Clinical-stage programs
RNA Viruses targeted
Prior development investment
Clinical Studies
explore

Discover Island Pharmaceuticals

company overview
Ebola
Discover
investor centre
Discover
multimedia
Pexels Cdc Library 3992925
Discover

Led by an experienced team, Island Pharmaceuticals brings decades of expertise in life sciences, clinical research, pharmaceutical development, and corporate advisory.

meet the team

Presentations

View all presentations

Presentations

View all presentations

Get the latest Island Pharmaceutical news alerts straight to your inbox

Stay in touch with our latest updates, investor news and media releases. 

Get the latest Island Pharmaceutical news alerts straight to your inbox

Stay in touch with our latest updates, investor news and media releases. 

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

These cookies are essential for the website to function and use its features, it also covers security and accessibility. You can read more about this in our Privacy Policy.

Performance cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.